Features
- Aquaform® Technology locks in moisture providing incredible, all-day comfort.
- More than 7x the parameter options of all competitive monthly brands allowing you to provide vision correction for 99.9% of your patients.1,2
- For every Biofinity® lens you fit, we partner with Plastic Bank® to fund the collection, processing, and conversion an equal amount of plastic, making Biofinity® net plastic neutral.*†3
- Clear vision with up to 6 nights/7 days of extended wear.
Family products
Help virtually all of your patients see the world their way1.With Biofinity®, you’re golden.
Biofinity® is the most trusted brand of frequent replacement contact lenses, named more than 2X as often as the next leading brand‡4.
Give your patients the care and contacts they deserve.
In the exam lane, you don’t just see a pair of eyes. You see the whole person: their health, well-being, and lifestyle. Explore a golden opportunity for your practice by prescribing the Biofinity® family of contact lenses1.
* Biofinity is defined as orders and includes Biofinity sphere, Biofinity Energys, Biofinity toric, Biofinity multifocal, Biofinity XR, Biofinity XR Toric, Biofinity toric multifocal product(s) sold and distributed by CooperVision in the US.
† Amount is defined as weight. Net plastic neutrality is established by purchasing credits from Plastic Bank. A credit represents the collection and conversion of one kilogram of plastic that may reach or be destined for waterways. CooperVision purchases credits equal to the weight of plastic in Biofinity orders in a specified time period. Biofinity plastic is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink).
‡ On average, Biofinity 46% most trusted vs. 19% for second ranked FRP brand. among ECPs that currently recommend Biofinity.
References:
1. CooperVision data on file 2021. Rx coverage database; 14-70 years.
2. CVI data on file, 2020. Based on number of parameter options available in the USA across all soft lenses from the 4 main manufacturers as reported by Tylers Quarterly Sept 2020.
3. CVI Data on file, 2022.
4. CVI data on file 2021. Decision Analyst online survey of 376 Biofinity prescribing ECPs in USA, Japan, Germany, France and Spain.